Cancer lab posts growth


  • By
  • | 2:56 p.m. March 1, 2016
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — Cancer-testing firm NeoGenomics posted sales growth of 9% in the fourth quarter on the heels of its acquisition of rival Clarient from GE Healthcare Life Services.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content